Development of Drug Delivery Systems Based on Layered Hydroxides for Nanomedicine

被引：52

作者：

Barahuie, Farahnaz ^{[1
]}

Hussein, Mohd Zobir ^{[1
]}

Fakurazi, Sharida ^{[2
,3
]}

Zainal, Zulkarnain ^{[1
]}

机构：

[1] Univ Putra Malaysia, Mat Synth & Characterizat Lab, Inst Adv Technol ITMA, Serdang 43400, Malaysia

[2] Univ Putra Malaysia, Inst Biosci, Lab Vaccines & Immunotherapeut, Serdang 43400, Malaysia

[3] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Human Anat, Serdang 43400, Malaysia

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2014年 / 15卷 / 05期

关键词：

layered hydroxides; nanomedicine; drug delivery; nanocomposite; nanocarrier; LDH; ZLH; cytotoxicity assay; CONVERTING-ENZYME-INHIBITORS; CONTROLLED-RELEASE PROPERTY; IN-VITRO; COMPARATIVE TOXICITY; NANOHYBRID COMPOUND; CELLULAR TOXICITY; SUSTAINED-RELEASE; ANTICANCER DRUG; UREA HYDROLYSIS; CAFFEIC ACID;

D O I：

10.3390/ijms15057750

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Layered hydroxides (LHs) have recently fascinated researchers due to their wide application in various fields. These inorganic nanoparticles, with excellent features as nanocarriers in drug delivery systems, have the potential to play an important role in healthcare. Owing to their outstanding ion-exchange capacity, many organic pharmaceutical drugs have been intercalated into the interlayer galleries of LHs and, consequently, novel nanodrugs or smart drugs may revolutionize in the treatment of diseases. Layered hydroxides, as green nanoreservoirs with sustained drug release and cell targeting properties hold great promise of improving health and prolonging life.

引用

页码：7750 / 7786

页数：37

共 50 条

[21] Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
Ranganathan, Ramya
Madanmohan, Shruthilaya
Kesavan, Akila
Baskar, Ganga
Krishnamoorthy, Yoganathan Ramia
Santosham, Roy
Ponraju, D.
Rayala, Suresh Kumar
Venkatraman, Ganesh
[J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2012, 7 : 1043 - 1060
[22] Protein-Based Nanomedicine Platforms for Drug Delivery
MaHam, Aihui
Tang, Zhiwen
Wu, Hong
Wang, Jun
Lin, Yuehe
[J]. SMALL, 2009, 5 (15) : 1706 - 1721
[23] Exploring the Application of Micellar Drug Delivery Systems in Cancer Nanomedicine
Wang, Qi
Atluri, Keerthi
Tiwari, Amit K.
Babu, R. Jayachandra
[J]. PHARMACEUTICALS, 2023, 16 (03)
[24] HSA-Based Drug Development and Drug Delivery Systems
Yang, Feng
Liang, Hong
[J]. CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (14) : 1784 - 1784
[25] A Special Issue on Reviews in Nanomedicine, Drug Delivery and Vaccine Development
Nalwa, Hari Singh
[J]. JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2014, 10 (09) : 1635 - 1640
[26] Development of Drug Delivery Technology and Nanomedicine by Using Gold Nanoparticles
Ozeki, Tetsuya
Tagami, Tatsuaki
[J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2021, 141 (03): : 323 - 326
[27] Careers in nanomedicine and drug delivery
Nance, Elizabeth
[J]. ADVANCED DRUG DELIVERY REVIEWS, 2019, 144 : 180 - 189
[28] Double Layered Hydroxides as Potential Anti-Cancer Drug Delivery Agents
Riaz, Ufana
Ashraf, S. M.
[J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (04) : 522 - 529
[29] Layered double hydroxides as a drug delivery system - Intercalation and controlled release of naproxen
Peng, Xia-Hui
Huang, Ke-Long
Jiao, Fei-Peng
Zhao, Xue-Hui
Yu, Jin-Gang
[J]. Gongneng Cailiao/Journal of Functional Materials, 2006, 37 (03): : 415 - 417
[30] Editorial: Nanomedicine and drug delivery
Kabanov, Alexander V.
Levon, Kalle
[J]. CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (36) : 4665 - 4667

← 1 2 3 4 5 →